Global Cord Blood (NYSE:CO) Coverage Initiated at StockNews.com

Equities researchers at StockNews.com started coverage on shares of Global Cord Blood (NYSE:CO) in a report released on Thursday. The brokerage set a “strong-buy” rating on the medical research company’s stock.

Global Cord Blood Price Performance

NYSE:CO opened at $1.00 on Thursday. The firm has a market capitalization of $121.55 million, a P/E ratio of 1.56 and a beta of 0.16. The company has a fifty day moving average of $1.26 and a 200 day moving average of $1.39. Global Cord Blood has a 52 week low of $2.03 and a 52 week high of $5.50.

About Global Cord Blood

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.